To confirm and expand the understanding of the role of FOLR1 in breast cancer, we compared expression of FOLR1 at the RNA and protein level in different subtypes of human breast cancer [(hormone receptor positive (ER+/PR+), HER2+, and TNBC] using both next generation sequencing and immunohistochemistry methods. This evidence concerns the gene PGR and breast carcinoma.